Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study
Thrombosis Research · 2023
DOI: 10.1016/j.thromres.2022.12.019 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Thrombosis Research, 2023. Verfasst von Jean-Christophe Gris und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, CHU Nîmes, Univ. Montpellier, Nîmes, France; Faculty of Pharmaceutical and Biological Sciences, Montpellier University, Fr…. Hauptthemen laut MEDLINE: COVID-19, Blood Coagulation Disorders, Thrombosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
INTRODUCTION: The prognostic significance of the thrombin generation assay (TGA) with a thrombomodulin (TM) challenge in patients entering hospital with severe COVID-19 is uncertain. METHODS: We prospectively evaluated an automated TGA (aTGA) using the ST-ThromboScreen® assay and ST-Genesia® analyser in 179 patients with severe COVID-19 during their admission to 2 university hospitals. The primary outcome was early survival at Day 28 (D28). Secondary outcomes were late survival at Day 90 (D90), later transfer to an intensive care unit (ICU), and occurrence of any thrombotic complications during hospitalisation. RESULTS: Among the 174 patients, 50 were initially admitted to ICUs. Forty-two were transferred to ICUs before D28. Fourteen patients, all in ICUs, died before D28, and 20 before D90, all but 1 in ICUs. None of the aTGA-derived results were associated with vital status either at D28 or D90. Nine patients had a thrombotic event with no association with the aTGA results. Later transfer to the ICU was associated with higher velocity index, thrombin peak height and endogenous thrombin potential (ETP) values of the aTGA performed with TM, and mainly with a lower TM-induced decrease in ETP (odds ratio 15.5 (2.15-132), p = 0.009). CONCLUSIONS: aTGA, a global assay supposed to evidence coagulopathy, could predict neither early or late survival, nor thrombotic events, in hospitalised COVID-19 patients. Its clinical justification in that setting is thus unlikely. A relative resistance of the ETP to TM was associated with later transfer to the ICU and deserves further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, CHU Nîmes, Univ. Montpellier, Nîmes, France; Faculty of Pharmaceutical and Biological Sciences, Montpellier University, France; UMR UA11 INSERM IDESP - Montpellier University, France; Departme…
- Department of Haematology, CHU Nîmes, Univ. Montpellier, Nîmes, France.
- BESPIM, CHU Nîmes, Univ. Montpellier, Nîmes, France.
- Department of Infectious and Tropical Diseases, CHU Nîmes, Univ Montpellier, Nîmes, France.
- Department of Anaesthesiology, Critical Care and Emergency Medicine, CHU Nîmes, Univ Montpellier, Nîmes, France.
- Department of Intensive Care Medicine, Lapeyronie Hospital, CHU Montpellier, Univ. Montpellier, Nîmes, France; Department of Vascular Medicine, CHU Montpellier, Univ. Montpellier, Nîmes, France.
Zitieren
APA
Gris, J. C., Guillotin, F., Dos Santos, T. P., Chéa, M., Loubet, P., Laureillard, D., Sotto, A., Muller, L., Barbar, S. D., Roger, C., Lefrant, J. Y., Jung, B., Klouche, K., Mura, T., Quéré, I., & Perez-Martin, A. (2023). Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study. Thrombosis Research. https://doi.org/10.1016/j.thromres.2022.12.019
Vancouver
Gris JC, Guillotin F, Dos Santos TP, Chéa M, Loubet P, Laureillard D, et al. Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study. Thrombosis Research. 2023. doi:10.1016/j.thromres.2022.12.019
BibTeX
@article{Gris2023,
author = {Gris, Jean-Christophe and Guillotin, Florence and Dos Santos, Taissa Pereira and Chéa, Mathias and Loubet, Paul and Laureillard, Didier and Sotto, Albert and Muller, Laurent and Barbar, Saber Davide and Roger, Claire and Lefrant, Jean-Yves and Jung, Boris and Klouche, Kada and Mura, Thibault and Quéré, Isabelle and Perez-Martin, Antonia},
title = {Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study},
journal = {Thrombosis Research},
year = {2023},
doi = {10.1016/j.thromres.2022.12.019}
}
EUVIMED